查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1937595

全球静脉血栓栓塞症治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Venous Thromboembolism Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 211 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计静脉血栓栓塞症治疗市场规模将从 2025 年的 18.9 亿美元成长到 2034 年的 28.2 亿美元，2026 年至 2034 年的复合年增长率为 4.53%。

受静脉血栓栓塞症（VTE）疾病（包括深层静脉栓塞症（DVT）和肺动脉栓塞（PE））盛行率不断上升的推动，VTE治疗市场正经历显着成长。随着人们对VTE相关风险的认识不断提高，医疗机构正将有效的预防和治疗策略置于优先地位。由于临床医师致力于改善患者预后并降低VTE相关併发症的发生率，包括直接口服抗凝血剂（DOAC）和传统抗凝血剂在内的抗凝血治疗需求激增。

治疗方案和给药方法的创新正在塑造VTE治疗市场的未来前景。新型抗凝血剂的研发，凭藉其更高的安全性和更优化的给药方案，正在改善VTE的治疗环境。此外，病患监测技术的进步，例如穿戴式装置和远端医疗解决方案，使医疗服务提供者能够更有效地追踪患者的用药依从性和治疗效果。随着对VTE潜在机制研究的深入，市场有望推出针对特定风险因素和患者群体的标靶治疗。

此外，随着製药公司和学术机构认识到该领域尚未满足的需求，加大对临床研究和开发的投入将对静脉血栓栓塞症（VTE）治疗市场产生积极影响。医疗服务提供者、研究人员和相关人员之间的合作对于推进临床试验和确保创新治疗方法的成功应用至关重要。在这种不断变化的环境下，监管机构有望简化新治疗方法的核准流程，并促进VTE患者快速获得有效治疗方法。随着预防、早期发现和个人化治疗方案的重要性日益凸显，将VTE管理纳入综合医疗保健策略以改善患者预后的重要性也将日益凸显。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球静脉血栓栓塞症治疗市场：依产品划分

  • 市场分析、洞察与预测
  • 非分段式气动压缩泵
  • 分段式无梯度气动压缩泵
  • 分段式气动压缩帮浦（含校准梯度）
  • 上肢气动加压袖套
  • 下肢气动加压袖套
  • 永久性下腔静脉滤器
  • 可回收下腔静脉滤器
  • 用于栓塞的球囊导管
  • 经皮血栓切除装置
  • 导管导引溶栓（CDT）装置

第五章 全球静脉血栓栓塞症治疗市场：依适应症划分

  • 市场分析、洞察与预测
  • 深层静脉栓塞症
  • 肺动脉栓塞

第六章 全球静脉血栓栓塞症治疗市场：依最终使用者划分

  • 市场分析、洞察与预测
  • 医院
  • 导管检查室
  • 门诊手术中心

第七章 全球静脉血栓栓塞症治疗市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Stryker Corporation
    • Argon Medical Devices
    • Cardinal Health（Medtronic）
    • Cook Medical
    • Boston Scientific Corporation
    • Koninklijke Philips NV
    • Arjo
    • DJO Global
简介目录
Product Code: VMR11215191

The Venous Thromboembolism Treatment Market size is expected to reach USD 2.82 Billion in 2034 from USD 1.89 Billion (2025) growing at a CAGR of 4.53% during 2026-2034.

The venous thromboembolism (VTE) treatment market is experiencing significant growth, driven by the increasing prevalence of VTE conditions, including deep vein thrombosis (DVT) and pulmonary embolism (PE). As awareness of the risks associated with VTE rises, healthcare providers are prioritizing effective prevention and treatment strategies. The market is witnessing a surge in demand for anticoagulant therapies, including direct oral anticoagulants (DOACs) and traditional anticoagulants, as clinicians seek to improve patient outcomes and reduce the incidence of VTE-related complications.

Innovations in treatment options and delivery methods are shaping the future of the VTE treatment market. The development of novel anticoagulant agents with improved safety profiles and dosing regimens is enhancing the therapeutic landscape for VTE management. Additionally, advancements in patient monitoring technologies, such as wearable devices and telehealth solutions, are enabling healthcare providers to track patient adherence and outcomes more effectively. As research continues to explore the underlying mechanisms of VTE, the market is likely to witness the introduction of targeted therapies that address specific risk factors and patient populations.

Moreover, the VTE treatment market will benefit from increased investment in clinical research and development, as pharmaceutical companies and academic institutions recognize the unmet needs in this area. Collaborative efforts between healthcare providers, researchers, and industry stakeholders will be essential in advancing clinical trials and ensuring the successful implementation of innovative therapies. As the landscape evolves, regulatory bodies are expected to streamline approval processes for new treatments, facilitating faster access to effective solutions for patients with VTE. The focus will increasingly shift towards integrating VTE management into comprehensive healthcare strategies, emphasizing the importance of prevention, early detection, and personalized treatment plans in improving patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Non-Segmented Pneumatic Compression Pumps
  • Segmented Pneumatic Compression Pumps without Gradient
  • Segmented Pneumatic Compression Pumps with Calibrated Gradient
  • Upper Pneumatic Compression Sleeves
  • Lower Pneumatic Compression Sleeves
  • Permanent Inferior Vena Cava Filters
  • Retrievable Inferior Vena Cava Filters
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) Devices

By Disease Indication

  • Deep Venous Thrombosis
  • Pulmonary Embolism

By End User

  • Hospitals
  • Catheterisation Laboratories
  • Ambulatory Surgical Centres

COMPANIES PROFILED

  • Stryker Corporation, Argon Medical Devices, Cardinal Health Medtronic, Cook Medical, Boston Scientific Corporation, Koninklijke Philips NV, Arjo, DJO Global

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN and Units)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Non-Segmented Pneumatic Compression Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.3. Segmented Pneumatic Compression Pumps without Gradient Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.4. Segmented Pneumatic Compression Pumps with Calibrated Gradient Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.5. Upper Pneumatic Compression Sleeves Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.6. Lower Pneumatic Compression Sleeves Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.7. Permanent Inferior Vena Cava Filters Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.8. Retrievable Inferior Vena Cava Filters Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.9. Embolectomy Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.10. Percutaneous Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.11. Catheter-Directed Thrombolysis (CDT) Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 5. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET: BY DISEASE INDICATION 2022-2034 (USD MN and Units)

  • 5.1. Market Analysis, Insights and Forecast Disease Indication
  • 5.2. Deep Venous Thrombosis Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 5.3. Pulmonary Embolism Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 6. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET: BY END USER 2022-2034 (USD MN and Units)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 6.3. Catheterisation Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 6.4. Ambulatory Surgical Centres Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 7. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET: BY REGION 2022-2034(USD MN and Units)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.2.1 By Product
    • 7.2.2 By Disease Indication
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.3.1 By Product
    • 7.3.2 By Disease Indication
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.4.1 By Product
    • 7.4.2 By Disease Indication
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.5.1 By Product
    • 7.5.2 By Disease Indication
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.6.1 By Product
    • 7.6.2 By Disease Indication
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL VENOUS THROMBOEMBOLISM TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Stryker Corporation
    • 9.2.2 Argon Medical Devices
    • 9.2.3 Cardinal Health (Medtronic)
    • 9.2.4 Cook Medical
    • 9.2.5 Boston Scientific Corporation
    • 9.2.6 Koninklijke Philips N.V
    • 9.2.7 Arjo
    • 9.2.8 DJO Global